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SUMMARY 
 
How adult tissue stem and niche cells respond to the nutritional state of an 
organism is not well understood. Here, we find that Paneth cells, a key 
constituent of the mammalian intestinal stem cell (ISC) niche, augment stem cell 
function in response to calorie restriction (CR). CR acts by reducing mTOR 
complex 1 (mTORC1) signaling in Paneth cells, and the ISC-enhancing effects of 
CR can be mimicked by rapamycin. Calorie intake regulates mTORC1 in Paneth 
cells, but not ISCs, and forced mTORC1 activation in Paneth cells during CR 
abolishes their effects on ISCs. Finally, increased expression in Paneth cells of 
bone stromal antigen 1 (Bst-1), an ectoenzyme that produces the paracrine factor 
cyclic ADP ribose (cADPR), mediates the effects of CR and rapamycin on ISC 
function. Our findings establish that mTORC1 non-cell autonomously regulates 
stem cell self-renewal, and highlight a significant role of the mammalian intestinal 
niche in coupling stem cell function to organismal physiology.  
 
Mammalian tissue-specific stem cells maintain tissue homeostasis by undergoing 
either self-renewing or differentiation divisions that generate more stem cells or 
restricted progenitors, respectively1. Stem cells often require cues from their 
microenvironment or “niche” to regulate their fates. Caloric restriction (CR), an 
intervention in which caloric intake is reduced while maintaining adequate nutrition, 
promotes longevity in diverse organisms, possibly by preserving stem and progenitor 
cell function2,3. In mice, CR promotes the generation of new neurons from neural 
progenitors and prevents the decline of hematopoietic stem cell numbers and function in 
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certain strains of mice with age2,4-7. These findings raise the question of how CR 
mediates these effects on stem cells, and whether the mammalian stem cell niche is 
involved. 
We have interrogated this question in the rapidly renewing mammalian small 
intestine. The intestine is organized into crypts that contain the stem cells and the 
rapidly dividing transient amplifying cells (TA-cells), and villi composed primarily of post-
mitotic absorptive enterocytes. In response to fasting and refeeding the intestine 
undergoes structural alterations such as changes in villi length, crypt depth, and cell 
turnover, suggesting that organismal physiology may modify intestinal progenitor 
function8,9. Recent studies have begun to define the identity of intestinal stem cells as 
well as their interaction with their Paneth cell niche10-15. Although no single marker 
identifies the entire ISC pool, Lgr5 is expressed by a majority of ISCs throughout the 
intestinal tract13,15. Lgr5+ ISCs (aka crypt base columnar cells or CBCs) can self-renew 
and differentiate for the life of the organism, and they reside at the base of crypts 
sandwiched between Paneth cells13,16. Loss of Paneth cells in vivo leads to reduced 
numbers of Lgr5+ ISCs, while the addition of Paneth cells to in vitro cultures 
dramatically increases the potential of Lgr5+ ISCs to form multipotent, self-renewing 
organoid bodies reminiscent of “mini-intestines”14. Thus, Paneth cells constitute a critical 
component of the stem cell niche both in vivo and in vitro13,14.  
 
CR increases stem and niche cell numbers 
To assess the effects of CR on intestinal homeostasis, we calorically restricted 
mice for 4 to 28 weeks, which is sufficient to observe many of the metabolic phenotypes 
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of CR17-19. Consistent with prior reports, CR mice had a 19.7± 5.8% loss in body mass 
compared to ad libitum (AL) fed counterparts (Supplementary Fig. 1a)20. In CR mice the 
small intestine was morphologically normal (Supplementary Fig. 1f), with no change in 
crypt density (Supplementary Fig. 1d), intestinal length (Supplementary Fig. 1c), or 
apoptotic cell frequency (Supplementary Fig. 3). However, it did have reduced mass 
(1.8±0.4 vs 1.4±0.2g, Supplementary Fig. 1b) with villi that were 15% shorter and 
possessed fewer enterocytes (Supplementary Fig. 1e, f). CR did not affect the 
frequency of chromogranin A+ enteroendocrine cells, but mildly reduced that of alcian 
blue+ secretory goblet cells (Supplementary Fig 2a, b). To address how CR influenced 
the frequency of ISCs, we performed in situ hybridization for Olfactomedin-4 (Olfm4), a 
recently described marker that is co-expressed by Lgr5+ ISCs21. CR led to a 35% 
increase in Olfm4+ primitive intestinal progenitors compared to those in AL mice (Fig. 
1a, Supplementary Fig. 6a).  Interestingly, CR also caused a commensurate increase in 
Cryptdin4+ Paneth cells (Fig. 1a), which we confirmed by morphological examination of 
one-micron tissue sections (Supplementary Fig. 4a) and by electron microscopy 
(Supplementary Fig. 4b). These findings lead to two intriguing conclusions: First, CR 
promotes the preservation and self-renewal of ISCs (increased Olfm4+ ISCs) at the 
expense of differentiation (shorter villi with fewer mature enterocytes).  Second, ISCs 
and their Paneth cells increase in tandem, raising the possibility that the Paneth cell 
niche may coordinate ISC adaptation to CR. 
The fact that CR augmented ISC numbers while reducing the total number of 
differentiated enterocytes suggested that CR enhances the proliferation of ISCs while 
reducing the proliferation of more differentiated progenitors (TA-cells). To test this 

5
possibility, we assessed incorporation of BrdU into ISCs and TA-cells. After a 4 hour 
pulse of BrdU, CR-crypts had nearly 2-fold as many BrdU+ ISCs compared to AL-crypts 
(4.3±0.3 vs 2.4±0.2, Fig. 1b; Supplementary Fig. 1g, h).  However, CR decreased the 
number of BrdU+ cells in the larger pool of TA-cells (11.0±0.9 vs 9.4±0.5; Fig. 1b), 
suggesting that output and migration into the villi from this compartment may also be 
reduced. Indeed, CR mice 24 hours after a single dose of BrdU had fewer absolute 
numbers of BrdU labeled cells in the villi compared to AL controls (14.5±1.5 vs 
19.0±1.7, Supplementary Fig. 1i, j). However, there was no significant difference in the 
percentage of BrdU+ villous enterocytes, indicating that in CR mice TA-cells generate 
fewer progeny for shorter, less cellular villi (Supplementary Fig. 1k). These data 
demonstrate that CR alters the coupling between stem cell and TA-cell proliferation in 
vivo.   
 
CR promotes intestinal regeneration 
Because CR increased the frequency and proliferation of ISCs we asked whether 
it also promotes the regeneration of the small intestinal epithelium. We tested the 
potential of isolated crypts, independent of intestinal stem cell markers, to form clonal, 
multipotent organoid bodies that posses all intestinal cell types in vitro22 (Supplementary 
Fig. 5). Crypts from CR mice were nearly 2-fold more likely to form organoid bodies than 
those from AL controls (Fig. 1c). These data suggest that CR leads to an increase in 
stem cell activity per crypt, as only stem cells are capable of self-renewing and 
differentiating into the various cell types that are required for organoid body formation 
and maintenance. 
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To ask whether CR also augments crypt regeneration in vivo, we used the 
clonogenic microcolony assay for testing ISC activity23. In AL and CR mice exposed to 
lethal doses of radiation and examined 72 hours later, CR significantly increased the 
number of surviving and regenerating crypts and Ki67+ intestinal progenitors per unit 
length of intestine (Fig. 1d, e). These data are consistent with our in vivo and in vitro 
data showing that CR increases the numbers and regenerative capacity of ISCs. 
 
CR enhances ISC function via the niche 
To understand how CR affects the frequency and function of ISCs and their 
Paneth cell niche, we performed CR experiments on Lgr5-EGFP-IRES-CreERT2 knock-
in mice, which allow isolation by flow cytometry of Lgr5-EGFPhi ISCs and their daughter, 
more differentiated EGFPlow cells16. Compared to AL controls, CR increased the 
frequency of Lgr5-EGFPhi ISCs (5.6±2.1% vs 4.3±1.9%, Fig. 1f) and Paneth cells 
(9.8±3.3% vs 6.7±3.3%, Fig. 1f, Supplementary Fig. 8, 9) by 1.5-fold. The frequency of 
the much larger pool of EGFPlow differentiated progenitors, however, was lower in CR 
(8.1±3.0% vs 10.1±4.3% Fig. 1f). These data corroborate the phenotypic expansion of 
ISCs and Paneth cells detected with the Olfm4 and Cryptdin4 markers, respectively 
(Fig.1a, Supplementary Fig. 6a, b), and suggest that while CR expands the pool of ISCs 
it leads to a reduction of more differentiated progenitors.  Thus, CR has opposing 
effects on the numbers of stem cells and their immediate progeny, shifting the 
equilibrium towards stem cell self-renewal. 
The enhanced regenerative activity of CR-crypts led us to ask whether ISCs 
respond to CR autonomously or non-autonomously through the Paneth cells. To test 
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this, we combined ISCs and Paneth cells isolated from CR and AL mice and assayed 
their ability to form organoid bodies in culture (Fig. 1g).  Consistent with prior 
studies14,22, neither Lgr5-EGFPhi ISCs nor Paneth cells established organoid bodies on 
their own, but, when cocultured, 15% of ISCs did generate organoid bodies (Fig. 1g,h).  
Interestingly, Paneth cells isolated from CR mice were significantly more likely than 
those from AL controls to promote organoid body formation when mixed with ISCs (Fig. 
1h), and this augmentation persisted even after 7 months of CR (Supplementary Fig. 6).  
In contrast, CR had neither a direct effect on ISC function (as CR or AL ISCs behaved 
similarly), nor did it boost the potential of EGFPlow progenitors to form organoid bodies 
(Fig. 1h, k). Ruling out the possibility that the enhancement caused by CR-Paneth cells 
resulted from an increase in their ability to home and attach to ISCs in culture, ISC-
Paneth cell doublets isolated from CR mice had a 3-fold increase compared to those 
from AL mice in their capacity to form organoid bodies (Fig. 1j). Not only did CR-Paneth 
cells promote primary organoid body formation, these organoids gave rise to more and 
larger secondary organoid bodies, even when individually subcloned (Fig. 1i, l). Thus, 
individual organoid bodies from CR-Paneth cells posses a greater ability to self-renew 
(Fig. 1l). The fact that Lgr5-EGFPhi ISCs form more organoid bodies when cocultured 
with CR-Paneth cells indicates that most Lgr5-EGFPhi cells harbor stem cell potential 
when exposed to the appropriate niche signals (Fig. 1h, k). 
 
Calorie intake activates mTORC1 in the niche 
Because the mTORC1 (mechanistic target of rapamycin complex 1) kinase is a 
major sensor of the organismal nutritional state, we asked whether CR mediates its 
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effects on Paneth cells through it24. Consistent with this, overnight fasting decreased 
phosphorylation of S6 (P-S6), a marker of mTORC1 activity in the intestine (Fig. 2a).  
Interestingly, feeding or insulin activated mTORC1 in Paneth cells but not in ISCs in a 
rapamycin-sensitive fashion (Fig. 2a). To confirm that we were observing Paneth cells, 
we cytospun isolated Paneth cells (>95% lysozyme+; Fig. 2b) and found that P-S6 
expression was indeed induced in the Paneth cells of fasted mice by insulin 
administration.  Similarly in immunoblots from isolated CR-crypts, phosphorylation of S6 
and S6K1, the latter being a direct substrate of mTORC1, were diminished (Fig. 2c).  
These data suggest that Paneth cells may modulate ISC function by sensing the 
organismal nutritional status through mTORC1.  
 
Niche mTORC1 mediates the effects of CR 
To address whether reduced mTORC1 signaling in Paneth cells enhances ISC 
function in response to CR, we generated mice in which the expression of Rheb2 (an 
mTORC1 activator) can be induced by doxycycline from the ubiquitously expressed 
ColA1 promoter (Rheb-tg) (Fig. 3a, b).  In mice fasted overnight, induction of Rheb2 
was sufficient to reactivate mTORC1 signaling in Paneth cells (Fig. 3c, d).  Interestingly, 
Rheb2 induction during CR blocked the increase in clonogenicity per crypt (Fig. 3e) 
normally caused by CR, prevented isolated Paneth cells from enhancing organoid 
formation when cultured with ISCs (Fig. 3f), and abolished the increase in Olfm4+ ISC 
and Cryptdin4+ Paneth cell numbers observed in CR in vivo (Supplementary Fig. 7a, b).  
To confirm that persistent mTORC1 activity negates the increase in Paneth cell 
frequency observed in CR, TSC1—a negative regulator of mTORC1—was excised 
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using TSC1loxp/loxp; Rosa26-CreERT2 mice.  The excision of TSC1 during CR (similar to 
Rheb2 induction) prevented the increase in Paneth cell frequency as assessed by flow 
cytometry (Supplementary Fig. 7c).  Thus, persistent mTORC1 activity during CR is 
sufficient to prevent CR-Paneth cells from promoting ISC function (Fig. 3e, f; 
Supplementary Fig. 7a-c).  
As constitutive activation of mTORC1 abrogated the effects of CR, we asked 
whether inhibition of mTORC1 with rapamycin mimics the effects of CR. Indeed, 
administration of rapamycin to mice increased the frequency of ISCs and Paneth cells 
by more than 1.5-fold (Fig. 3g, h), and crypts isolated from mice treated for just 1 week 
with rapamycin were as capable of forming organoid bodies as those from mice on CR 
(Fig. 3i). Furthermore, rapamycin increased the clonogenicity of crypts irrespective of 
whether they were isolated from adult intestines expressing or lacking Rictor, a 
necessary and specific component of mTORC2 (Fig. 3k)25.  These data indicate that 
rapamycin mediates this enhancement in crypt clonogenicity by inhibiting mTORC1 and 
does so independently of mTORC2.  
Like CR, rapamycin acts non-autonomously because when Paneth cells isolated 
from rapamycin-treated mice were mixed with ISCs from control or rapamycin-treated 
mice, they caused a prominent increase in the formation of primary and subcloned 
secondary organoid bodies (Fig. 3j, l, m). Moreover, rapamycin treatment and CR did 
not have additive effects on either the ability of crypts (Fig. 3i) or Paneth cells (Fig. 3j, l) 
to form organoid bodies, suggesting that CR mediates many of its effects by reducing 
mTORC1.  These data, together with the finding that CR and rapamycin have non-
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additive effects (Fig. 3i, j), demonstrate that CR and rapamycin indirectly promote ISC 
function and do so by reducing mTORC1 signaling in Paneth cells. 
 
CR boosts Bst-1 levels in Paneth cells 
Several observations suggest that CR and rapamycin induce a state in Paneth 
cells that is quite stable. For example, Paneth cells taken from CR- or rapamycin-
treated mice maintain their augmented capacity to promote ISC self-renewal even when 
placed in nutrient rich media that should activate mTORC1 (Fig. 1h, 3l). Similarly, 
Paneth cells isolated from mice that had been on CR, but were returned to an AL diet 
for 3 days, also retain an enhanced capacity to promote ISC function in the organoid 
assay (Fig. 1m). To gain mechanistic insight into how CR mediates its effects in Paneth 
cells, we undertook gene expression profiling of Paneth cells isolated by flow cytometry 
from AL and CR mice (n= 3 and 4, respectively). CR significantly changed the 
expression of 401 genes (p<0.01), including 57 that encode cell surface or secreted 
proteins; however, there were no changes in pathways previously implicated in 
mediating the Paneth cell and ISC interaction, such as Wnt or Notch (Fig. 4a, b, 
Supplementary Table 1)14.   
Of the genes upregulated by CR, we focused on bone stromal antigen 1 (Bst-1) 
because its expression in bone marrow stromal cells promotes the proliferation of 
hematopoietic progenitors26. Bst-1 is an ectoenzyme that converts NAD+ to cyclic ADP 
ribose (cADPR), a paracrine effector that enters responder cells via nucleoside 
transporters to activate calcium signaling and promote proliferation. CR increased Bst-1 
mRNA and protein expression in Paneth cells and caused a shift in its SDS-PAGE 
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mobility suggestive of protein processing (Fig. 4b-e). Interestingly, while the addition of 
cADPR to crypt culture boosted the organoid-forming potential of AL-crypts, it did not 
augment the ability of CR-crypts to form organoids (Fig. 4e).  Lastly, we asked whether 
Bst-1 was necessary to mediate the effects of CR in the organoid formation assay (Fig. 
4f, g).  Indeed, knockdown of Bst-1 mRNA with 2 independent functional siRNAs 
abrogated the enhanced capacity of CR-crypts to form organoids, and the addition of 
exogenous cADPR was sufficient to rescue the loss of Bst-1.  These data demonstrate 
that CR, in an mTORC1-regulated manner, induces Bst-1 in Paneth cells, that Bst-1 is 
necessary to mediate many of the effects of CR, and that cADPR substitutes for Bst-1 in 
the organoid assay. 
 
Discussion 
Our data favor a model in which the mammalian intestinal stem cell niche 
couples organismal nutritional status to stem cell function. Reduced calorie intake leads 
to more ISC self-renewal (expansion of phenotypic ISCs in vivo), an accompanying 
increase in the ISC niche, and to an increase in ISC function and regeneration in vivo 
and in vitro.  Although it is unclear why CR increases ISC numbers and function, one 
possibility is that in low calorie conditions it may be advantageous for ISCs to slightly 
shift the balance towards self-renewal while reducing the pool and proliferation of more 
differentiated TA-cells.  Preserving or increasing the stem cell pool may better prepare 
the intestine for rapid regeneration once nutrients become available and so enable 
organisms to adapt to periods of prolonged famine interspersed with times of abundant 
food. 
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Non-cell autonomous mechanisms also orchestrate intestinal remodeling in the 
Drosophila mid-gut, highlighting the importance of the stem cell niche as a sensor of 
organismal physiology in diverse species27. Fasting in Drosophila diminishes ISC 
numbers while refeeding dramatically expands them. In contrast, we find that CR in the 
murine intestine preserves the numbers of ISCs, but reduces the numbers and output of 
TA cells.  Flexible intestinal adaptation in the fly gut occurs by direct modulation of ISCs, 
the only cells capable of proliferation, while in the murine intestine such adaptation can 
be achieved by differentially regulating ISCs and the larger, more proliferative pool of 
TA cells.  In both systems, however, ISCs respond to organismal demands in part by 
niche signals. 
CR mediates many of its effects on ISCs by reducing mTORC1 signaling in the 
ISC niche, emphasizing the importance of non-cell autonomous mechanisms in 
intestinal adaptation and regeneration. Moreover, our data raise the intriguing possibility 
that the use mTORC1 inhibitors or Bst-1 mimetics, such as FDA-approved drugs like 
rapamycin or cADPR, respectively, may have a use in improving intestinal regeneration 
and function in patients.  It remains to be determined whether persistent mTORC1 
activity in the ISC niche accounts for intestinal atrophy in intestinal diseases, and 
whether CR or rapamycin treatment can improve intestinal regeneration in these 
patients.  
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The Rheb2 transgenic mouse was produced as described28 using the human Rheb2 
(hsRheb2) coding sequence. Mice used in this study include Lgr5-EGFP-IRES-
CreERT2, Rosa26-CreERT2, UbiquitinC-CreERT2 (all obtained from the Jackson 
Laboratory), Rictorloxp, and TSCloxp.  All were maintained on a C57BL/6 background. CR 
was achieved by providing individual or paired mice a daily portion of a chow diet 
fortified with vitamins and minerals amounting to 60% of the daily food intake of their ad 
libitum counterparts20. All mice used in CR experiments were between the ages of 10 to 
24 weeks and were sacrificed prior to their daily feeding. Intestinal crypts and ISCs were 
isolated and cultured as adapted from 14,22. Unless otherwise indicated, data are 
presented as means ± s.d and two-tailed Student’s t-tests were used to assess 
statistical significance (*P<0.05, **P<0.01, ***P<0.001). 
 
 
Materials and Method  
 
Mice and Calorie restriction 
 
Mice were housed in the Unit for Laboratory Animal Medicine at the Whitehead Institute 
for Biomedical Research. Lgr5-EGFP-IRES-CreERT2 mice (Strain name: B6.129P2-
Lgr5tm1(cre/ERT2)Cle/J, Stock Number: 008875) were purchased from Jackson 
Laboratories. UbiquitinC-CreERT2 mice were obtained from the Jackson Laboratory 
(Strain Name: B6;129S-Tg(UBC-cre/ERT2)1Ejb/J, Stock Number: 007001). Rictor 
floxed mice were generated as described in 29 and backcrossed to C57BL/6 for at least 
6 generations. TSC1loxp/loxp mice were the generous gift of D. Kwiatkowski (Harvard 
Medical School) and backcrossed to C57BL/6 for at least 6 generations. Rosa26-
CreERT2 mice (Rosa26 or R26) were obtained from the Jackson Laboratory (Strain 
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Name: B6.129-Gt(ROSA)26Sortm1(cre/ERT2)Tyj/J, Stock Number 008463). CR was 
achieved by providing individual or paired mice a daily portion of a chow diet fortified 
with vitamins and minerals amounting to 60% of the daily food intake of their ad libitum 
counterparts20. All adult mice used in CR experiments were between the ages of 10 to 
24 weeks and were sacrificed prior to their daily feeding. Rictor or TSC1 was excised by 
treatment with tamoxifen suspended in corn or sunflower seed oil (Spectrum) at a 
concentration of 10 mg/mL, and 200 μl per 25 g of body weight was injected 
intraperitoneally into mice once daily for 5-7 days. Control animals received an equal 
volume of the tamoxifen suspension, but did not express the CreERT2 fusion protein. 
Mice were allowed to recover for at least 7 days after the last tamoxifen injection prior to 
any experiments. In vivo fate mapping in Lgr5-EGFP-IRES-CreERT2;Rosa26loxpstoploxp-
LacZ compound mice was done with a single injection of tamoxifen given at 200 μl per 
25 g. As described previously30, rapamycin (LC Laboratories) was administered by 
intraperitoneal injection for 7 to 28 consecutive doses at 4 mg/kg. It was reconstituted in 
absolute ethanol at 10 mg/ml and diluted in 5% Tween-80 (Sigma) and 5% PEG-400 
(Hampton Research) before injection. The final volume of all injections was 200 μl. 
Regular insulin (Lilly) was administered at 0.75 U/kg diluted in PBS 20 minutes prior to 
sacrificing fasted mice. 
 
Generation of Rheb2 Transgenic mouse 
The Rheb2 transgenic mouse was produced as described before in 28. Briefly, mouse 
embryonic stem cells (KH2) were obtained containing a neomycin resistance gene as 
well as a hygromycin resistance gene lacking a promoter and an ATG start codon at the 
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ColA1 locus. The presence of frt sites flanking the neomycin and hygromycin resistant 
genes allows site-specific integration of the transgene at the ColA1 locus. These 
embryonic cells also contain an M2rtTA transactivator at the endogenous Rosa26 
promoter, which, in the presence of doxycycline, leads to the transactivation of TetO-
promoter driven transgenes. The human Rheb2 (hsRheb2) coding sequence was 
cloned into a vector downstream of a TetO promoter that also contained a PKG-ATG-frt 
element necessary for frt-site integration. This vector, along with another vector 
contained the FLPe recombinase, were then electroporated into the KH2 cells. As a 
result, the coding sequence for hsRheb2 along with a PGK promoter and the ATG 
initiation codon necessary for the expression of the hygromycin resistance gene is 
integrated into the genomic DNA of the KH2 cells at the ColA1 locus. Cells with properly 
integrated hsRheb2 were then selected by hygromycin resistance and subsequently 
injected into blastocysts. Chimeric mice were then mated with C57BL/6J mice until 
germline transmission of the transgene was achieved. 
PCR genotyping of the hsRheb2 transgenic mouse was performed with the following 
primers: Rheb-tg_F: CCAATTTGTGGAAGGCGAGTT, Rheb2-TG_R: 
CCATGGCCTTCATGTAGCTT 
 
Immunohistochemistry/fluorescence 
Tissues were fixed in 10% formalin, paraffin embedded, and sectioned. Antigen retrieval 
was performed with Borg Decloaker RTU solution (Biocare Medical) in a pressurized 
Decloaking Chamber (Biocare Medical) for 3 minutes.  Antibodies: rat anti-BrdU 
(1:2000; Abcam 6326), rabbit phospho-S6 Ser235/236 (1:500, CST 4858), rabbit 
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cleaved caspase 3 (1:500; CST 9664), rabbit chromogranin A (1:3000, Abcam 15160), 
rabbit Lysozyme (1:2000; Thermo), rabbit Bst-1 (1:1000, Abcam 74301) and mouse Bst-
1 (1:100 to 500, BD Pharmingen).  For mouse Bst-1, the M.O.M (mouse on mouse) kit 
was used according to the manufacturer’s instructions (Vector labs PK-2200).  Biotin 
conjugated secondary donkey anti-rabbit or rat antibodies were used from Jackson 
ImmunoResearch.  The Vectastain Elite ABC immunoperoxidase detection kit (Vector 
Labs PK-6101) followed by Dako Liquid DAB+ Substrate (Dako) was used for 
visualization. For immunofluorescence Alexa Fluor 568 secondary antibodies 
(Invitrogen) were used.  All antibody incubations were performed with Common 
Antibody Diluent (Biogenex) 
 
In situ hybridization 
The in situ probes used in this study correspond to expressed sequence tags or fully 
sequenced cDNAs obtained from Open Biosystems. The accession numbers (IMAGE 
mouse cDNA clone in parenthesis) for these probes are as follow: mouse OLFM4 
BC141127 (9055739), mouse cryptdin4 BC134360 (40134597).  To ensure the 
specificity of the probes, we generated both sense and antisense probes by in vitro 
transcription using DIG RNA labelling mix (Roche) according to the manufacturer’s 
instructions and to previously published detailed methods21,31. 
 
Radiation and clonogenic microcolony assay 
AL and CR adult mice were exposed to 15 Gy of ionizing irradiation from a 137-Cesium 
source (GammaCell) and sacrificed after 72 hours. The number of surviving crypts per 
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length of the intestine was enumerated from H&E-stained sections. 
 
Immunoblotting 
Antibodies: rabbit anti phospho-T389 S6K1, phospho-S240/244 S6, S6K1, and S6 from 
CST; rabbit Bst-1 (ab74301) from Abcam; mouse anti -actin (clone AC-15) from 
Sigma. Crypts or tissue were rinsed once with ice-cold PBS and lysed in ice-cold lysis 
buffer (50 mM HEPES [pH 7.4], 40 mM NaCl, 2 mM EDTA, 1.5 mM sodium 
orthovanadate, 50 mM NaF, 10 mM pyrophosphate, 10 mM glycerophosphate, and 1% 
Triton X-100, and one tablet of EDTA-free protease inhibitors [Roche] per 25 ml). The 
soluble fractions of cell lysates were isolated by centrifugation at 13,000 rpm for 10 min. 
Proteins extracts were denatured by the addition of sample buffer, boiled for 5 min, 
resolved by SDS-PAGE, and analyzed by immunoblotting. 
 
Flow cytometry and isolation of ISCs and Paneth cells 
Small intestines were removed and the fat/mesentery was dissected away. The 
intestinal lumen was washed with ice cold PBS (Mg-/Ca-) using a 18G feeding needle 
(Roboz FN-7905) until the intestines appeared white/pink. They were then opened 
longitudinally. The mucous was removed by gently rubbing the intestine between fingers 
in cold PBS. The intestines were cut into 3 to 5 mm fragments and placed into 50 ml 
conical tubes that were fill with ice cold 30 ml of PBS (Mg-/Ca-)/EDTA (10 mM). The 
samples were incubated and shook intermittently on ice for 30 minutes continuously 
discarding and replacing (at least 3 times) the supernatant. The fragments were then 
continually resuspended with ice cold 30ml PBS (Mg-/Ca-)/EDTA (10 mM) and 
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intermittently shook on ice for 10 minutes, discarding the supernatant again for 3 times. 
The fragments were resuspended again with ice cold 30 ml PBS (Mg-/Ca-)/EDTA (10 
mM) and incubated and intermittently shook while waiting on ice for 20 to 40 minutes. 
The samples were then triturated with a 10 ml pipette 1 to 2 times, and the contents 
were filtered twice through a 70-μm mesh (BD Falcon) into a 50 ml conical tube to 
remove villous material and tissue fragments. At this point the suspension was mainly 
composed of crypts. Crypts were removed from this step for crypt culture experiments 
and embeded in matrigel with crypt culture media. For ISC isolation, the crypt 
suspensions were centrifuged for 5 minutes at 250 g (4C or room temperature). The 
pellets were gently resuspended in 1.0 ml of undiluted TrypLE Express (Invitrogen) + 
120 μl of DNase I (10U/μl , Roche) and transferred to 15 ml conical tubes. The samples 
were incubated in a 32° C water bath for 1.25 to 2 minutes, were not titurated, and were 
then placed on ice.  12 ml of cold SMEM was added to each sample and were gently 
triturated twice. The samples were then centrifuged for 5 minutes at 250 g. The pellets 
were resuspended and incubated for 15 minutes on ice in 0.5 to 1 ml SMEM that 
contained an antibody cocktail consisting of CD45-PE (eBioscience, 30-F11), CD31-PE 
(Biolegend, Mec13.3), Ter119-PE (Biolegend, Ter119), CD24-Pacific Blue (Biolegend, 
M1/69) and EPCAM-APC (eBioscience, G8.8). 12 ml of SMEM were added and the 
samples were centrifuged for 5 minutes at 250 g. The pellets were resuspended with 
0.5-2 ml (depending on the size of the pellet) of SMEM/ 7-AAD solution (1:500 dilution). 
The samples were filtered through a 40-μm mesh (BD Falcon) prior to cell sorting.  ISCs 
were isolated as Lgr5-EGFPhiEpcam+CD24low/-CD31-Ter119-CD45-7-AAD-, EGFPlow 
progenitors were isolated as EGFPlowEpcam+CD24low/-CD31-Ter119-CD45-7-AAD-, and 

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Paneth cells were isolated as CD24hiSideScatterhiLgr5-EGFP-Epcam+CD31-Ter119-
CD45-7-AAD- with a BD FACS Aria II SORP cell sorter into supplemented crypt culture 
medium.  Dead cells were excluded from the analysis with the viability dye 7-AAD. 
When indicated, populations were cytospun (Thermo Cytospin 4) at 800 rpm for 2min, 
or allowed to settle at 37°C in fully humidified chambers containing 6% CO2 onto poly-
L-lysine coated slides (Polysciences). The cells were subsequently fixed in 4% 
paraformaldehyde (pH=7.4, Electron Microscopy Sciences) prior to staining. 
 
Crypt culture media  
 
Isolated crypts were counted and embeded in matrigel (BD Bioscience 356231 growth 
factor reduced) that contains 1 μM Jagged (Ana-Spec) at 5-10 crypts/μl and cultured in 
a modified form of medium as described in 22. Briefly, DMEM/F12 (Gibco) was 
supplemented by EGF 40 ng/ml (R&D), Noggin 200 ng/ml (Peprotech), R-spondin 500 
ng/ml (R&D or Sino Biological), N-Acetyl-L-cysteine 1 μM (Sigma-Aldrich) and Y-27632 
dihydrochloride monohydrate 20 ng/ml (Sigma-Aldrich). cADPR (Sigma), when 
indicated, was added to culture at 50 μM. 30-50 μl drops of matrigel with crypts were 
plated onto a flat bottom 48-well plate (Corning 3548) and allowed to solidify for 20 to 30 
minutes in a 37° C incubator. 350 μl of crypt culture medium was then overlaid onto the 
matrigel, changed every other day, and maintained at 37°C in fully humidified chambers 
containing 6% CO2. Clonogenicity (colony-forming efficiency) was calculated by plating 
50 to 400 crypts and assessing organoid formation 3 to 7 days after initiation of cultures. 
 
Culture of isolated cells in supplemented crypt culture medium 
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Isolated ISCs or Paneth cells were centrifuged for 5 minutes at 250 g and then 
resuspended in the appropriate volume of crypt culture medium (500-1000cells/μl) 
supplemented with 1x N2 (Invitrogen), 1x B27 (Invitrogen), 100 ng/ml Wnt-3A (R&D), 
and with additional 500 ng/ml R-Spondin to yield 1 μg/ml final concentration. ISCs were 
then seeded into matrigel (BD Bioscience 356231 growth factor reduced) containing 1 
μM Jagged (Ana-Spec) up to 5,000-10,000 cells/30-50 μl. 30 μl drops of 65% matrigel 
were plated onto a flat bottom 48-well plate (Corning 3548) and then Paneth cells were 
added at the same cell count to the top of the matrigel drop.  Alternatively, ISCs and 
Paneth cells were mixed after sorting in a 1:1 ratio, centrifuged, and then seeded into 
matrigel.  The matrigel drops with ISCs and Paneth cells were allowed to solidify for 20 
to 30 minutes in a 37° C incubator.  350 μl of crypt culture medium was then overlayed 
onto the drops of matrigel and maintained at 37°C in fully humidified chambers 
containing 6% CO2. The crypt media was changed every second day.  Organoid bodies 
were quantitated on days 3, 7, and 9 days of culture, unless otherwise specified.  In 
subcloning experiments, either individual or cultures of organoids were manually 
disrupted as indicated in the text on day 7-9 by rigorous tituration and replated into fresh 
matrigel; these secondary organoid bodies were quantitated on day 18 after initiation of 
the primary cultures.  When indicated, crypts were transfected with 100nM siRNAs 
targeting the Bst-1 (Thermo Scientific, J-044021-11 and J-044021-12) using the X-
Tremegene siRNA transfection reagent, by incubating the crypts at +37°C for 30 min 
with transfection mixture in crypt medium before mounting to matrigel. 
 
Microarray analysis and validation 
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Approximately 100,000 Paneth cells were harvested directly to the RLT buffer of the 
RNeasy plus extraction kit (Qiagen) by the flowcytometry isolation protocol. Total RNA 
extracts were subjected to microarray analysis by standard protocols of the Whitehead 
Institute Genome Technology Core 
(http://jura.wi.mit.edu/genomecorewiki/index.php/Main_Page) using GeneChip Mouse 
Gene 1.0 ST arrays (Affymetrix).  Expression analysis was conducted with the help of 
Whitehead Institute Bioinformatics and Research Computing. Briefly, CEL-files were 
preprocessed with RMA using Bioconductor and the package oligo, and differential 
expression was assayed by moderated t-test, as implemented by limma.  Expression 
changes were validated by qRT-PCR using oligos:  
Bst-1 ACCCCATTCCTAGGGACAAG, GCCTCCAATCTGTCTTCCAG,  
Wnt3a GGGAGAAATGCCACTGTGTT, TCTCCGCCCTCAAGTAAGAA,  
Myc TCTCCACTCACCAGCACAAC, TCGTCTGCTTGAATGGACAG,  
Gapdh TGTTCCTACCCCCAATGTGT, TGTGAGGGAGATGCTCAGTG  
 
 
Electron Microscopy 
 
Immediately after removal from the animal, 1.0 mm sections of mouse intestine were 
placed into Karnovsky’s KII Solution (2.5% glutaraldehyde, 2.0% paraformaldehyde, 
0.025% calcium chloride, in a 0.1 M sodium cacodylate buffer, pH 7.4), fixed overnight 
at 4° C, and stored in cold buffer. Subsequently, they were post-fixed in 2.0% osmium 
tetroxide, stained en bloc with uranyl acetate, dehydrated in graded ethanol solutions, 
infiltrated with propylene oxide/Epon mixtures, flat embedded in pure Epon, and 
polymerized over night at 60°C.  One micron sections were cut, stained with toluidine 
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blue, and examined by light microscopy.  Representative areas were chosen for 
electron microscopic study and the Epon blocks were trimmed accordingly.  Thin 
sections were cut with an LKB 8801 ultramicrotome and diamond knife, stained with 
Sato’s lead, and examined in a FEI Morgagni transmission electron microscope. Images 
were captured with an AMT (Advanced Microscopy Techiques) 2K digital CCD camera.  
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Figure Legends 
 
Figure 1. Calorie restriction augments the capacity of Paneth cells to boost ISC 
function. a. Olfm4+ ISCs and Cryptdin4+ Paneth cells were increased in CR mice (in 
situ hybridization, proximal jejunum, n=3). b. Crypt base columnar cells (CB-cells) 
showed a 2-fold increase in BrdU incorporation and TA-cells revealed a reduction after 
a 4-hour pulse in CR mice (n=3). c. CR-crypts were 2-fold more capable of forming 
organoids (n=8). Representative AL and CR-organoids are shown at 5 days (red 
arrowhead marks organoids and yellow asterisk indicates aborted crypts; scale bar = 50 
μm). d-e.  CR increased the number of surviving (d) and proliferating (e, Ki67+) crypts 
after irradiation induced damage (n=3 for d and e). f. Schematic demonstrating dark 
green Lgr5hi ISCs, red Paneth cells, and light green EGFPlow progenitors. CR increased 
ISCs (dark green) and Paneth cells (red) by 1.5-fold, and reduced EGFPlow (light green) 
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progenitors by 20% (CR, n=27; AL, n=26). g. A schematic illustrating the mixing of ISCs 
with Paneth cells in matrigel. h. Organoid formation per Lgr5hi ISCs cocultured with 
Paneth cells from CR mice was significantly increased (n=5). Representative image of 
primary organoids at day 7. i. Dissociated organoids derived from CR-Paneth cells gave 
rise to larger secondary organoids at day 18 (n=5). j. Sorted ISC-Paneth cell doublets 
plated at clonal density (50-100 doublets per 30 ul droplet of matrigel) demonstrated 
that CR-doublets had nearly 3-fold more organoid potential (n=3). k.  EGFPlow 
progenitors harbored little organoid potential (n=4). l. Subcloning of individual CR-
Paneth derived organoids gave rise to 3-fold more secondary organoids (27 organoids 
from 3 independent mice per condition were analyzed, shades of grey or blue denote 
separate mice). m. Paneth cells isolated from mice that had been on CR, but were 
returned to an AL diet for 3 days, also retained an augmented capacity to promote 
organoid formation (n=3). (Unless other wise indicated, in all panels: values = mean; 
error bars = s.d.; scale bars= 50 μm; * indicates P<0.05; ** P<0.01; and *** P<0.001). 
 
Figure 2. Nutritional regulation of mTORC1 in Paneth cells 
a. Overnight fasted mice treated without or with rapamcyin were refed for 5 hours and 
intestinal sections immunostained for phospho-S6 (P-S6). Refeeding or administration 
of insulin activates mTORC1 in Paneth cells (arrow heads) but not ISCs (arrows, n=3-5, 
scale bar = 20 μm). b. Similar results were observed in cytospun preparations of sorted 
Paneth cells that were confirmed to be greater than 95% positive for the Paneth cell 
marker Lysozyme (n=3).  P-S6 was reduced in sorted Paneth cells from fasted mice and 
was induced 20 minutes after injection with insulin. c. Immunoblots of isolated crypts 
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from CR mice show reduced phosphorylation of known mTORC1 substrates phospho-
S6K1 (P-S6K1) and P-S6.  
 
Figure 3. mTORC1 signaling in Paneth cells mediates the effects of calorie 
restriction on ISC function 
a. Schematic of the Tet-ON human Rheb2 transgene (Rheb-tg). b. Doxycycline (dox) 
induced Rheb2 protein and S6 phosphorylation in the liver (background band: B.G.). c-
d. Fasted Rheb-tg mice demonstrated increased immunostaining of P-S6 in intestinal 
epithelium (c) and in isolated Paneth cells (d) upon dox injection. e-f. Induction of 
Rheb2 from the start of CR abrogated the enhancement in organoid formation per crypt 
(n=3) (e) and per Lgr5hi ISC cocultured with Paneth cells (n=5) (f). g-h. Rapamycin (R) 
(n=13) increased the frequency of Lgr5hi ISCs (g) and Paneth cells (h) compared to 
vehicle (V) (n=14) as measured by flow cytometry.  i-j. Organoid potential of intestinal 
crypts (n=3) (i) and AL Lgr5hi ISCs with Paneth cells (n=5) (j) from R, CR, or CR+R 
treated mice. k. Rapamycin increased crypt organoid formation in Rictor deleted 
Rictorfl/flUBC-CreERT2 mice (n=3) to a similar extent as in wild-type (WT) mice. l. 
Organoid formation of Lgr5hi ISCs combined with Paneth cells from rapamycin treated 
mice was significantly increased in comparison to Paneth cells from vehicle treated 
mice (n=5). m. Dissociated primary organoids derived from R-Paneth cells gave rise to 
more secondary organoids (n=5). (Unless otherwise indicated, in all panels: values = 
mean; error bars = s.d.; scale bars= 20 μm; * indicates P<0.05; ** P<0.01; and *** 
P<0.001). 
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Figure 4.  Calorie restriction enhances expression of bone stromal antigen 1 (Bst-
1) in Paneth cells, whose product cyclic ADP ribose (cADPR) enhances ISC 
function 
a. Transcriptional profiling of Paneth cells from CR and AL mice (n=4 and 3, 
respectively) identified significant expression changes in 401 genes, 57 of which encode 
plasma membrane associated or secreted proteins. b. Validation of the increased 
transcription of Bst-1 by qRT-PCR (n=3). c-d. Increased Bst-1 protein in crypts from CR 
mice and rapamycin treated mice detected via immunoblotting (c) and in CR-Paneth 
cells by immunostaining (d). e. Exogenous cADPR increased the organoid potential of 
AL-crypts to an extent similar as those of CR-crypts (n=3). f-g Inhibition of Bst-1 by 
siRNA-mediated knock-down (n=3) (f) abrogated the enhanced potential of CR-crypts to 
form organoids (n=3) (g). i. A model of intestinal adaptation to calorie restriction by non-
cell autonomous regulation of ISC self-renewal. CR attenuates mTORC1 activity in the 
Paneth cells, resulting in increased expression of Bst-1, whose paracrine product 
cADPR promotes ISC self-renewal. * indicates P<0.05; ** P<0.01, *** P<0.001. Values 
= means and error bars = s.d. 
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